Big Data Helps Find the Achilles Heel of Each Individual Cancer – Facts So Romantic

In January, the pharmaceutical company Roche paid more than a billion dollars to buy about half of a small company called Foundation Medicine. Foundation has not invented any new drugs or life-saving devices. Most insurance companies won’t pay for its main product, and like a lot of biotech companies, it loses money.

The big bucks are for Foundation’s information. Roche, Foundation, and many other cancer researchers now believe that thinking about cancer in terms of data is going to be the way to beat the disease. The deal gives Roche access to Foundation’s database, which holds the DNA sequences of the tumors of 35,000 cancer patients, along with information about what kinds of drugs they were treated with and how good those drugs were at beating back the cancer.

Traditionally oncology has been information poor. Cancers have been categorized and treated based on what body part they afflict, how the cells look under a microscope, and how much the tumor had spread, leading to a diagnosis like “Stage 2 colon cancer.” This typology has become more sophisticated over the years, but it still lumps lots of cancers together. It’s like doing a census of Noah’s ark and concluding that the boat…
Read More…

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s